Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/72530
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJittiporn Wongpunen_US
dc.contributor.authorTeera Chanmaneeen_US
dc.contributor.authorChainarong Tocharusen_US
dc.contributor.authorRatchanaporn Chokchaisirien_US
dc.contributor.authorSuphakit Chantornen_US
dc.contributor.authorWachirachai Pabuprapapen_US
dc.contributor.authorApichart Suksamrarnen_US
dc.contributor.authorJiraporn Tocharusen_US
dc.date.accessioned2022-05-27T08:26:28Z-
dc.date.available2022-05-27T08:26:28Z-
dc.date.issued2022-04-01en_US
dc.identifier.issn1618095Xen_US
dc.identifier.issn09447113en_US
dc.identifier.other2-s2.0-85123608976en_US
dc.identifier.other10.1016/j.phymed.2022.153925en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85123608976&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/72530-
dc.description.abstractBackground: Festidinol is a flavan-3-ol which has been shown to reduce advanced glycation end products (AGEs) and reactive oxygen species, both of which play a crucial role in the pathology of many neurodegenerative diseases. Purpose: This study aimed to investigate the effects of festidinol on oxidative stress, amyloidogenesis, phosphorylated tau (pTau) expression, synaptic function, and cognitive impairment, and the potential mechanisms involved, in a mouse model with an Alzheimer-like pathology. Methods: D-galactose (150 mg/kg) and aluminum chloride (10 mg/kg) were injected intraperitoneally into 40 mice for 90 days to generate an AD mouse model with cognitive impairment. Festidinol (30 mg/kg) and donepezil (5 mg/kg) were then administered orally for 90 days after which behavior and molecular changes in the brain were measured. Results: The aluminum accumulated and the expression of the cell senescence marker P16 increased after exposure to D-galactose and AlCl3 (2.5 ± 0.5 mg/kg, 149.1 ± 28.1% of control, respectively). Festidinol markedly decreased the escape latency (8.7 ± 4.3 s) and increased the number of platform crossings (8 ± 1.4 time) in the Morris water maze test. Superoxide dismutase activity was significantly elevated after festidinol administration, however there were significant reductions in the levels of 4‑hydroxy-2-nonenal, receptor for advanced glycation end products, phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells (pNF-κB), and nuclear factor of activated T cells 1 (NFAT1). Festidinol attenuated amyloid beta production by reducing the mRNA of beta-site APP cleaving enzyme 1 (BACE1). Festidinol also significantly decreased the expression of pTau and phosphorylated glycogen synthase kinase 3 (148.6 ± 37.6% of control, 125.3 ± 22.6% of control, respectively). Conclusion: Festidinol can ameliorate learning and memory impairments by modulating amyloidogenesis, tau hyperphosphorylation, cholinergic activity, neuroinflammation, and oxidative stress, and by regulating the brain-derived neurotrophic factor signaling pathway.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleThe effects of festidinol treatment on the D-galactose and aluminum chloride–induced Alzheimer-like pathology in mouse brainen_US
dc.typeJournalen_US
article.title.sourcetitlePhytomedicineen_US
article.volume98en_US
article.stream.affiliationsUniversity of Phayaoen_US
article.stream.affiliationsFaculty of Medicine, Chiang Mai Universityen_US
article.stream.affiliationsRamkhamhaeng Universityen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.